Alemtuzumab until minimal residual disease for chronic lymphocytic leukemia: Is it a new standard? [12]

Research output: Contribution to journalLetter

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)7240-7241
Number of pages2
JournalJournal of Clinical Oncology
Volume23
Issue number28
DOIs
StatePublished - Dec 1 2005

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this